Cevenfacta Evrópusambandið - íslenska - EMA (European Medicines Agency)

cevenfacta

laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.

Hemgenix Evrópusambandið - íslenska - EMA (European Medicines Agency)

hemgenix

csl behring gmbh - etranacogene dezaparvovec - hemophilia b - other hematological agents - treatment of severe and moderately severe haemophilia b (congenital factor ix deficiency) in adult patients without a history of factor ix inhibitors.

Sotyktu Evrópusambandið - íslenska - EMA (European Medicines Agency)

sotyktu

bristol-myers squibb pharma eeig - deucravacitinib - psoriasis - Ónæmisbælandi lyf - treatment of moderate-to-severe plaque psoriasis in adults.

Aripiprazol W&H Tafla 15 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

aripiprazol w&h tafla 15 mg

williams & halls ehf. - aripiprazolum inn - tafla - 15 mg

Fragmin Stungulyf, lausn í áfylltri sprautu með nálarvörn 12.500 and-Xa a.e. Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 12.500 and-xa a.e.

pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 12.500 and-xa a.e.

Posaconazol Zentiva (Posaconazol Alvogen) Magasýruþolin tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

posaconazol zentiva (posaconazol alvogen) magasýruþolin tafla 100 mg

zentiva k.s.* - posaconazolum inn - magasýruþolin tafla - 100 mg

Fragmin Stungulyf, lausn í áfylltri sprautu með nálarvörn 7.500 and-Xa a.e. Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 7.500 and-xa a.e.

pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 7.500 and-xa a.e.

Fragmin Stungulyf, lausn í áfylltri sprautu 15.000 anti-Xa IU Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn í áfylltri sprautu 15.000 anti-xa iu

pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 15.000 anti-xa iu

Fragmin Stungulyf, lausn í áfylltri sprautu 5.000 anti-Xa IU Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn í áfylltri sprautu 5.000 anti-xa iu

pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 5.000 anti-xa iu

Fragmin Stungulyf, lausn 25.000 and-Xa a.e./ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

fragmin stungulyf, lausn 25.000 and-xa a.e./ml

pfizer aps - dalteparinum natricum inn - stungulyf, lausn - 25.000 and-xa a.e./ml